Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 7
ID1260ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandMyoblocCompanySolstice NeurosciencesPhysical AppearanceClear and colorless to light-yellow sterile injectable solutionRoute of AdministartionInjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1261ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandNeuroblocCompanySolstice NeurosciencesPhysical AppearanceClear and colourless to light yellow solutionRoute of AdministartionIntramuscular InjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1419ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandBOTOX CompanyAllerganPhysical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type ARoute of AdministartionIntramuscular, intradetrusor and intradermal useCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1420ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandDysportCompanyIpsen PharmaceuticalsPhysical AppearanceSterile vial for reconstitutionRoute of AdministartionIntramuscular InjectionCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1421ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandXeominCompanyMERZ AESTHETICSPhysical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.Route of AdministartionIntramuscular InjectionCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1534ThPPIDTh1113NameGlatiramer AcetatePeptide SequenceEAYKAAEKAYAAKEAAKEAA Full viewLength52Functional ClassificationIIaDiseaseNeurological DisorderBrandCopaxoneCompanyTeva Pharmaceutical IndustriesPhysical AppearanceClear, colorless to slightly yellow, sterile, nonpyrogenic solutionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1812ThPPIDTh1203NamePeginterferon beta-1aPeptide SequenceNA Full viewLength0Functional ClassificationIaDiseaseNeurological DisorderBrandPlegridyCompanyBiogen Canada IncPhysical AppearanceSterile SolutionRoute of AdministartionSubcutaneousCategoryNA Target